Pubblicazioni 2016

Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study

Falanga A, Santoro A, Labianca R, De Braud F, Gasparini G, D’Alessio A, Barni S, Iacoviello L; HYPERCAN Study Group.

Thromb Res. 2016;140 Suppl 1:S55-9.